Financial Year |
March 31 2023 |
Monetary Funds |
63,376,096.95 |
Held-for-trading Financial Assets |
24,001,883.83 |
Notes Receivable |
2,083,938.09 |
Accounts Receivable |
120,908,603.71 |
Advances to Suppliers |
28,078,883.41 |
Other Receivables |
9,127,148.02 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
249,243,140.14 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
18,630,694.74 |
Total Current Assets |
515,450,388.89 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
592,310,709.05 |
Under-construction Projects |
191,933,012.57 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
111,926,874.09 |
R&D expenses |
-- |
Goodwill |
1,757,651.91 |
Long-Term Deferred and Prepaid Expenses |
1,748,144.66 |
Deferred Income Tax Assets |
14,219,864.22 |
Other Non-Current Assets |
46,634,112.05 |
Sub-Total of Non-Current Assets |
964,166,416.17 |
Total Assets |
1,479,616,805.06 |
Short-Term Loans |
30,000,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
12,257,826.30 |
Accounts Payable |
197,802,136.11 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
13,274,005.37 |
Taxes Payable |
7,647,904.88 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
940,959.79 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,211,999.78 |
Other Current Liabilities |
173,014.71 |
Sub-Total of Current Liabilities |
270,920,443.58 |
Long-term Loans |
50,000,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
5,461,450.51 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
128,477,876.89 |
Total Liabilities |
399,398,320.47 |
Paid-In Capital(Or Share Stock) |
144,927,653.00 |
Capital Surplus |
482,495,807.63 |
Surplus Reserve |
45,020,686.90 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
372,125,366.45 |
Minority Stockholder's Interest |
35,779,223.24 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,044,439,261.35 |
Owner's Equity(Stockholder's Equity) |
1,080,218,484.59 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,479,616,805.06 |